Dosing related effects of zoledronic acid on bone markers and creatinine clearance in patients with multiple myeloma and metastatic breast cancer.

Søe, Kent; Delaissé, Jean-Marie; Jakobsen, Erik H; Hansen, Charlotte T; Plesner, Torben

Søe, Kent; Delaissé, Jean-Marie; Jakobsen, Erik H; Hansen, Charlotte T; Plesner, Torben.

Affiliation

Søe K; Clinical Cell Biology, Vejle Hospital/Lillebaelt Hospital, Institute of Regional Health Research, University of Southern Denmark , Vejle , Denmark.

Acta Oncol ; 53(4): 547-56, 2014 Apr.

Article in En | MEDLINE | ID: mdl-24164102

Subject(s)

Biomarkers, Tumor/analysis; Bone Density Conservation Agents/therapeutic use; Bone Neoplasms/drug therapy; Breast Neoplasms/drug therapy; Creatinine/urine; Diphosphonates/therapeutic use; Imidazoles/therapeutic use; Multiple Myeloma/drug therapy; Adult; Bone Neoplasms/metabolism; Bone Neoplasms/secondary; Breast Neoplasms/metabolism; Breast Neoplasms/pathology; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma/metabolism; Multiple Myeloma/pathology; Neoplasm Staging; Prognosis; Prospective Studies; Radioimmunoassay; Zoledronic Acid

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Neoplasms / Breast Neoplasms / Biomarkers, Tumor / Creatinine / Diphosphonates / Bone Density Conservation Agents / Imidazoles / Multiple Myeloma Type of study: Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2014 Document type: Article Affiliation country: Denmark Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google